Functional Mitral Regurgitation clinical trials at UCSF
2 research studies open to eligible people
Functional mitral regurgitation is when the mitral valve in the heart leaks, causing blood to move backward. UCSF is researching a new treatment to see if it can safely repair this valve. They are also testing another method to help heart failure patients with valve problems.
Edwards PASCAL CLASP IID/IIF Pivotal Clinical Trial
open to eligible people ages 18 years and up
To establish the safety and effectiveness of the Edwards PASCAL Transcatheter Valve Repair System in patients with degenerative mitral regurgitation (DMR) who have been determined to be at prohibitive risk for mitral valve surgery by the Heart Team, and in patients with functional mitral regurgitation (FMR) on guideline directed medical therapy (GDMT)
San Francisco, California and other locations
EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With at Least Mild FMR
open to eligible people ages 18 years and up
The objective of this prospective, randomized, blinded clinical trial is to assess the safety and efficacy of the Carillon Mitral Contour System in treating heart failure with functional regurgitation (FMR).
San Francisco, California and other locations
Our lead scientists for Functional Mitral Regurgitation research studies include Richard Cheng, MD Sammy Elmariah, MD.
Last updated: